Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The CHEC-SC Cohort Study: CHaractErizing CFTR Modulated Changes in Sweat Chloride and Their Association With Clinical Outcomes

NCT03350828 is registered in ClinicalTrials.gov with Nicole Hamblett as lead sponsor.

NCT NCT03350828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03350828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The CHEC-SC Cohort Study: CHaractErizing CFTR Modulated Changes in Sweat Chloride and Their Association With Clinical Outcomes
Lead sponsor
Nicole Hamblett
Phase
Observational
Overall status
Active, not recruiting
Start date
January 15, 2018
Completion date
December 31, 2026
Enrollment
5,000 (estimated)
Sites
52

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis